Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia has convened an ordinary shareholders’ meeting for 29 June 2026 in Turin to approve its 2025 standalone and consolidated financial statements and decide on the allocation of profit for the year. Shareholders will also vote on the 2026 remuneration policy, review pay for 2025, and decide on the appointment and compensation of new boards of directors and statutory auditors, shaping the company’s governance for the coming mandate.
The meeting will be held on a single call with participation and voting permitted exclusively via a designated representative, Computershare S.p.A., in line with Italian corporate law and the company’s by-laws. Fidia reiterates the record date, intermediary communication requirements, and confirms that no shareholders yet benefit from its increased voting rights mechanism, details that are important for investors in assessing control dynamics and exercising their rights.
More about Fidia Spa
Fidia S.p.A. is an Italian joint-stock company based in Turin and listed on Euronext Milan. The company operates in the industrial and technology sector, with its shares identified by ISIN code IT0005654683, and maintains a share capital of €11.85 million represented by more than 249 million ordinary shares, including a small portion held as treasury shares.
Average Trading Volume: 7,039,678
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.76M
See more data about FDA stock on TipRanks’ Stock Analysis page.